- Home
- ANTX vs SDST Comparison
ANTX vs SDST Comparison
Compare ANTX & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- SDST
- Stock Information
- Founded
- ANTX 2017
- SDST 2022
- Country
- ANTX United States
- SDST United States
- Employees
- ANTX N/A
- SDST N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- SDST Blank Checks
- Sector
- ANTX Health Care
- SDST Finance
- Exchange
- ANTX Nasdaq
- SDST Nasdaq
- Market Cap
- ANTX 31.4M
- SDST 34.3M
- IPO Year
- ANTX 2022
- SDST N/A
- Fundamental
- Price
- ANTX $1.29
- SDST $2.85
- Analyst Decision
- ANTX Buy
- SDST Buy
- Analyst Count
- ANTX 2
- SDST 2
- Target Price
- ANTX $2.00
- SDST $17.00
- AVG Volume (30 Days)
- ANTX 89.4K
- SDST 128.2K
- Earning Date
- ANTX 11-12-2025
- SDST 11-12-2025
- Dividend Yield
- ANTX N/A
- SDST N/A
- EPS Growth
- ANTX N/A
- SDST N/A
- EPS
- ANTX N/A
- SDST N/A
- Revenue
- ANTX N/A
- SDST N/A
- Revenue This Year
- ANTX N/A
- SDST N/A
- Revenue Next Year
- ANTX N/A
- SDST N/A
- P/E Ratio
- ANTX N/A
- SDST N/A
- Revenue Growth
- ANTX N/A
- SDST N/A
- 52 Week Low
- ANTX $0.98
- SDST $1.43
- 52 Week High
- ANTX $1.68
- SDST $125.60
- Technical
- Relative Strength Index (RSI)
- ANTX 62.56
- SDST 36.00
- Support Level
- ANTX $1.22
- SDST $2.62
- Resistance Level
- ANTX $1.33
- SDST $2.90
- Average True Range (ATR)
- ANTX 0.09
- SDST 0.26
- MACD
- ANTX 0.01
- SDST -0.04
- Stochastic Oscillator
- ANTX 64.86
- SDST 16.67
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).